Lauren Pearson
No Rating Available
(Learn About Our Rating System)

Lauren Pearson, DO, MPH

Languages spoken: English

  • Dr. Pearson is an Associate Professor (Clinical) in the Department of Pathology at the University of Utah. She serves as the Chief Medical Officer for ARUP at University of Utah in Salt Lake City. She is board certified in anatomic and clinical pathology.

    Dr. Pearson’s academic interests include pathology education, quality control, analytical interferences, instrumentation, and laboratory stewardship.

    Specialties

    • Pathology

    Board Certification

    American Board of Pathology (Anatomic & Clinical)
    National Board of Osteopathic Medical Examiners

  • Dr. Pearson is an Associate Professor (Clinical) in the Department of Pathology at the University of Utah. She serves as the Chief Medical Officer for ARUP at University of Utah in Salt Lake City. She is board certified in anatomic and clinical pathology.

    Dr. Pearson’s academic interests include pathology education, quality control, analytical interferences, instrumentation, and laboratory stewardship.

    Board Certification and Academic Information

    Academic Departments Pathology -Primary
    Board Certification
    American Board of Pathology (Anatomic & Clinical)
    National Board of Osteopathic Medical Examiners

    Education history

    Chief Resident Anatomic and Clinical Pathology - University of Vermont College of Medicine/University of Vermont Medical Center Chief Resident
    Anatomic and Clinical Pathology - University of Vermont College of Medicine/University of Vermont Medical Center Resident
    Professional Medical Osteopathic Medicine/Community Health Track - Touro University California D.O., M.P.H.
    Molecular, Cell and Developmental Biology - University of California, Santa Cruz B.S.

    Selected Publications

    Journal Article

    1. Potter S, Rudolf JW, Pearson LN (2024). Rainbow phlebotomy collection and urine aliquots for emergency department add-on testing in the era of pandemic-driven supply shortages. Lab Med. (Read full article)
    2. Mathewson NJ, Pearson LN, Doyle K (2023). Abnormal Hb A1c Result from a Diabetic Patient Leads to Unexpected Diagnosis. Clin Chem, 69(7), 684-687. (Read full article)
    3. Pandya V, Nguyen Sorenson AHT, Jones E, Young BA, Pearson LN (2022). Spirited away: Can ethanol testing in add-on orders provide meaningful results? Clin Biochem, 115, 97-102. (Read full article)
    4. Genzen JR, Souers RJ, Pearson LN, Manthei DM, Chambliss AB, Shajani-Yi Z, Miller WG (2022). Reported Awareness and Adoption of 2021 Estimated Glomerular Filtration Rate Equations Among US Clinical Laboratories, March 2022. JAMA, 328(20), 2060-2062. (Read full article)
    5. Pearson LN, Johnson SA, Greene DN, Chambliss AB, Farnsworth CW, French D, Herman DS, Kavsak PA, Merrill AE, Lo SM, Lyon ME, SoRelle JA, Schmidt RL (2020). Side-Effects of COVID-19 on Patient Care: An INR Story. J Appl Lab Med, 6(4), 953-961. (Read full article)
    6. Okoye NC, Barker AP, Curtis K, Orlandi RR, Snavely EA, Wright C, Hanson KE, Pearson LN (2021). Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting. J Clin Microbiol, 59(4). (Read full article)
    7. Pearson LN, Schmidt RL, Cahoon K, Pelt CE (2020). Reliability of Total Nucleated Cell Counts in the Setting of Hip Arthroplasty. J Appl Lab Med, 6(3), 679-687. (Read full article)
    8. Schmidt RL, Moore RA, Pearson LN (2020). The costs and benefits of cross-level quality control rules. Clin Chim Acta, 510, 697-702. (Read full article)
    9. Pearson LN, Moser KA, Schmidt RL (2020). D-Dimer Varies Widely Across Instrument Platforms and is Not a Reliable Indicator of Periprosthetic Joint Infections. Arthroplast Today, 6(4), 686-688. (Read full article)
    10. Goold E, Pearson L, Johnson LM (2020). Can fecal calprotectin serve as a screen for necrotizing enterocolitis in infants? Clin Biochem. (Read full article)
    11. Walker BS, Pearson LN, Schmidt RL (2019). An Analysis of Multirules for Monitoring Assay Quality Control. Lab Med, 51(1), 94-98. (Read full article)
    12. Schumacher JA, Holgard VD, Sial F, Pearson LN, Patel JL, Karner KH (2019). Detection and Quantification of FLT3 Internal Tandem Duplication Mutations Do Not Vary Significantly Between Whole Blood and Blast-Enriched Samples. Am J Clin Pathol, 153(2), 251-257. (Read full article)
    13. Schmidt RL, Pearson LN (2019). Estimating the cost of quality of errors in the analytical phase. Clin Chim Acta, 495, 60-66. (Read full article)
    14. Schmidt RL, Pearson LN (2019). Quality control optimization part I: Metrics for evaluating predictive performance of quality control. Clin Chim Acta, 495, 174-184. (Read full article)
    15. Schmidt RL, Pearson LN (2019). Quality control optimization part II: A method to optimize the accuracy of laboratory quality control. Clin Chim Acta, 495, 233-238. (Read full article)
    16. Pearson LN, Schmidt RL (2018). Adoption of Evidence-Based Medicine in Clinical Laboratory Science: A Survey of the Prevalence of Systematic and Narrative Reviews. Lab Med, 50(3), 223-228. (Read full article)
    17. Gruzdys V, Cahoon K, Pearson L, Lehman CM (2019). Method Verification Shows a Negative Bias between 2 Procalcitonin Methods at Medical Decision Concentrations. J Appl Lab Med, 4(1), 69-77. (Read full article)
    18. Pearson LN, Miller JM, Lunde JH, Bryant RJ, Lewis MR, Tang ME (2019). Combined Pathology-Driven Algorithmic Testing and Integrated Reporting for Bone Marrow Examination. Arch Pathol Lab Med, 143(6), 732-737. (Read full article)
    19. Adams A, Straseski JA, Lehman CM, Pearson LN (2018). Peritoneal and Pleural Fluid Chemistry Measurements Performed on Three Chemistry Platforms. Lab Med, 50(2), 145-149. (Read full article)
    20. Lehman CM, Pearson L, Salmond J, Raphael K, Schmidt RL (2018). A Reflex Protocol for Creatinine Testing Reduces Costs and Maintains Patient Safety. Lab Med, 50(2), 202-207. (Read full article)
    21. Metcalf RA, Calvaresi E, Tonna JE, Blaylock R, Pearson L (2018). Severe intravascular hemolysis following extracorporeal right ventricular assist device placement. Transfusion, 59(4), 1178-1179. (Read full article)
    22. Schmidt RL, Pearson LN (2018). Is your assay stable? Using process stability and capability to evaluate assay performance. Clin Chim Acta, 490, 28-33. (Read full article)
    23. Schmidt RL, Walker BS, Pearson LN (2018). Quality control limits: Are we setting them too wide? Clin Chim Acta, 486, 329-334. (Read full article)
    24. Pearson LN, Layfield LJ, Schmidt RL (2018). Cost-effectiveness of rapid on-site evaluation of the adequacy of FNA cytology samples performed by nonpathologists. Cancer Cytopathol, 126(10), 839-845. (Read full article)
    25. Pearson L, Factor RE, White SK, Walker BS, Layfield LJ, Schmidt RL (2018). Rapid On-Site Evaluation of Fine-Needle Aspiration by Non-Cytopathologists: A Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies for Adequacy Assessment. Acta Cytol, 62(4), 244-252. (Read full article)
    26. Layfield LJ, Pearson L, Walker BS, White SK, Schmidt RL (2018). Diagnostic Accuracy of Fine-Needle Aspiration Cytology for Discrimination of Squamous Cell Carcinoma from Adenocarcinoma in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Acta Cytol, 62(5-6), 318-326. (Read full article)
    27. De Luca-Johnson J, Ninfea JI, Pearson L, Conant J, Bryant R, Zakai NA, Tang ME (2016). Myeloid Neoplasms with t(5;12) and ETV6-ACSL6 Gene Fusion, Potential Mimickers of Myeloid Neoplasm with PDGFRB Rearrangement: Case Report with Imatinib Therapy and Review of the Literature. Case Rep Med, 2016, 8324791. (Read full article)

    Letter

    1. Genzen JR, Souers RJ, Pearson LN, Manthei DM, Chambliss AB, Shajani-Yi Z, Miller WG (2023). An Update on Reported Adoption of 2021 CKD-EPI Estimated Glomerular Filtration Rate Equations. [Letter to the editor]. Clin Chem, 69(10), 1197-1199. (Read full article)
    2. Moser KA, Pearson LN, Pelt CE, Olson JD, Goodwin AJ, Isom JA, Harris NS, Pham HP, Smock KJ, Unold D, VanSandt AM, Volod O, Chen D (2020). Letter to the Editor on "The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria". [Letter to the editor]. J Arthroplasty, 35(9), 2682-2683. (Read full article)